Have a feature idea you'd love to see implemented? Let us know!

ENSC Ensysce Biosciences Inc

Price (delayed)

$0.4905

Market cap

$9.6M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.07

Enterprise value

$5.83M

Highlights
ENSC's quick ratio has soared by 175% YoY and by 119% from the previous quarter
ENSC's net income is up by 37% year-on-year and by 30% since the previous quarter
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 9% YoY

Key stats

What are the main financial stats of ENSC
Market
Shares outstanding
19.57M
Market cap
$9.6M
Enterprise value
$5.83M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.6
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$6.3M
EBITDA
-$6.3M
Free cash flow
-$8.54M
Per share
EPS
-$2.07
Free cash flow per share
-$0.86
Book value per share
$0.82
Revenue per share
$0
TBVPS
$0.95
Balance sheet
Total assets
$9.38M
Total liabilities
$2.8M
Debt
$387,176
Equity
$6.91M
Working capital
$6.29M
Liquidity
Debt to equity
0.06
Current ratio
3.24
Quick ratio
2.12
Net debt/EBITDA
0.6
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-158.8%
Return on equity
-261.1%
Return on invested capital
-812.4%
Return on capital employed
-95.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ENSC stock price

How has the Ensysce Biosciences stock price performed over time
Intraday
-10.82%
1 week
-2.13%
1 month
-15.21%
1 year
-48.67%
YTD
-53.73%
QTD
104.38%

Financial performance

How have Ensysce Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.31M
Net income
-$7.93M
Gross margin
N/A
Net margin
N/A
Ensysce Biosciences's operating income has surged by 54% YoY and by 35% QoQ
ENSC's net income is up by 37% year-on-year and by 30% since the previous quarter

Growth

What is Ensysce Biosciences's growth rate over time

Valuation

What is Ensysce Biosciences stock price valuation
P/E
N/A
P/B
0.6
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 31% QoQ and by 16% YoY

Efficiency

How efficient is Ensysce Biosciences business performance
Ensysce Biosciences's return on invested capital has surged by 92% QoQ
ENSC's return on equity has surged by 89% year-on-year and by 61% since the previous quarter
The company's return on assets has surged by 51% QoQ and by 39% YoY

Dividends

What is ENSC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ENSC.

Financial health

How did Ensysce Biosciences financials performed over time
Ensysce Biosciences's total assets has surged by 192% YoY
ENSC's quick ratio has soared by 175% YoY and by 119% from the previous quarter
Ensysce Biosciences's debt is 94% less than its equity
ENSC's debt to equity has shrunk by 76% QoQ and by 75% YoY
Ensysce Biosciences's debt has decreased by 15% from the previous quarter but it has increased by 9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.